Recall Register

Food, drugs, devices › Ethicon, Inc.

Device recall: Coated VICRYL Polyglactin 910 Suture VIO 36IN(90CM) USP0(M3.5) S/A CT, Product Number J358H

FDA enforcement event 95516 · Class II · initiated 25 Sep 2024 · status Ongoing

DeviceVoluntary: Firm initiated1 product recordRaritan, NJ

FDA enforcement event 95516 is a device recall by Ethicon, Inc. of Raritan, NJ, initiated 25 Sep 2024 and classified Class II, with 1 product record.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 87% of the 970 device enforcement events initiated in 2024 carry the same class.

Status: Ongoing. Initiation: voluntary: firm initiated. Ethicon, Inc. has 36 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Ethicon, Inc., Raritan, NJ.

Reason for recall

"Complaints were received regarding needle pull-off and suture degradation. Analysis on returned product from this lot confirmed that some sutures were visually degraded in the package."

Distribution

"International distribution to the country of China."

Product records

Recall numberProductQuantityClassStatusReport date
Z-0319-2025Coated VICRYL Polyglactin 910 Suture VIO 36IN(90CM) USP0(M3.5) S/A CT, Product Number J358H31,032 unitsClass IIOngoing13 Nov 2024

Context

87%of 2024 device events are Class II970 events that year
1product record in this eventfirm median: 1
36events on this register for the firm

Other enforcement events for Ethicon, Inc.

InitiatedProduct (first record)TypeClassRecords
8 Oct 2024MONOCRYL" (poliglecaprone 25) Suture REF Y936H MONOCRYL" Sutures are indicated for use in general soft tissue approximatDeviceClass II1
10 May 2024VICRYL (polyglactin 910) Suture - Indicated for use in general soft tissue approximation and/or ligation, including use DeviceClass II6
23 Apr 2024SURGIFOAM" Absorbable Gelatin Powder Kit, Product Code 1979.DeviceClass II1
8 Mar 2024STRATAFIX Spiral MONOCRYL Plus Bidirectional Knotless Tissue Control Device: STRATAFIX SPIRAL MONOCRYL PLUS BI UD 12+12IDeviceClass II1
31 Mar 2023PDS¿ Plus Antibacterial (polydioxanone) Suture - PDS PLUS CLR 27IN(70CM) USP3-0(M2) S/A PC-25 PRIME. Intended for use inDeviceClass II1
16 Nov 2022PDS II (polydioxanone) Suture- VIOLET MONOFILAMENT 27IN 0 S/A CT-1 Product Code: Z340H For use in soft tissue approximatDeviceClass II1
20 Sep 2022STRATAFIX SPIRAL PGA-PCL UNI UD 20CM USP2-0(M3) S/A SH. indicated for use in soft tissue approximation where the use of DeviceClass II1
8 Aug 2022PDS II (polydioxanone) Suture, Product Code Z771D 4-0 PDS Suture, Violet, 8x18" (45cm), SH-1 Control Release NeedlesDeviceClass II1
24 Mar 2022STRATAFIX SPIRAL PGA-PCL UNI UD sizes: [20CM USP2-0(M3) S/A RB-1, product code: SXMD1B403-12] and [30CM USP2-0(M3) S/A PDeviceClass II1
4 Jan 2021Ethicon Dermabond Advanced Topical Skin Adhesive-topical skin adhesive to hold closed easily approximated skin edges of DeviceClass II1

All 36 events for Ethicon, Inc.

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "Complaints were received regarding needle pull-off and suture degradation. Analysis on returned product from this lot confirmed that some sutures were visually degraded in the package."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "International distribution to the country of China."

Is the recall still ongoing?

FDA lists the status as Ongoing. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.